E2F activity is biphasically regulated by androgens in LNCaP cells

Biochemical and Biophysical Research Communications

Volumn 283, Issue 1, 2001, Pages 97-101

  Hofman, Kurt ^a   Swinnen, Johannes V ^a   Verhoeven, Guido ^a   Heyns, Walter ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Androgens; Differentiation; E2F; LNCaP; P27KIP1; Proliferation; Prostate cancer; Retinoblastoma

Indexed keywords

ANDROGEN; CYCLIN A; GENE PRODUCT; MESSENGER RNA; METRIBOLONE; PROSTATE SPECIFIC ANTIGEN; PROTEIN P27; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

EID: 0034789649     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4738     Document Type: Article

References (28)

1. Control of LNCaP proliferation and differentiation: Actions and interactions of androgens, 1alpha,25-dihydroxy-cholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate
2. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line
3. Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells
4. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells
5. E2F and the molecular mechanisms of early cell-cycle control
6. E2F-1F-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product
7. Mechanism of active transcriptional repression by the retinoblastoma protein
8. The regulation of E2F by pRB-family proteins
9. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein
10. Rb function in cell-cycle regulation and apoptosis
11. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP
12. Apparent coactivation due to interference of expression constructs with nuclear receptor expression
13. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP
14. Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence
15. Regulation of androgen-dependent prostatic cancer cell growth: Androgen regulation of CDK2, CDK4, and CKI p16 genes
16. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells
17. Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats
18. Progression of LNCaP prostate tumor cells during androgen deprivation: Hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest
19. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kipl expression
20. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
21. Role of p27 in prostate carcinogenesis
22. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27Kip1
23. Distinct altered patterns of p27Kip1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
24. Androgen receptor signalling in the prostate
25. Androgen receptor - An update of mechanisms of action in prostate cancer
26. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation
27. Androgen receptor - An update of mechanisms in prostate cancer
28. Rapid signalling by androgen receptor in prostate cancer cells